Table 2.
Arrestin3 expression and clinical markers
| Variable | N (%) | Mean intensity Arr3 |
Standard error |
P value |
|---|---|---|---|---|
| ER status | ||||
| Negative | 203 (45) | 1151 | ±25 | 0.092 |
| Positive | 246 (55) | 1207 | ±22 | |
| PR status | ||||
| Negative | 206 (47) | 1203 | ±26 | 0.171 |
| Positive | 234 (53) | 1157 | ±22 | |
| Her2 subtype | ||||
| Other | 409 (93) | 1190 | ±18 | 0.014* |
| HER2 Subtype | 33 (7) | 1033 | ±56 | |
| Triple negative status | ||||
| ER-/PR-/HER2- | 101 (23) | 1227 | ±39 | 0.123 |
| Other | 341 (77) | 1165 | ±19 | |
| Lymph node status | ||||
| Negative | 212 (47) | 1191 | ±23 | 0.771 |
| Positive | 238 (53) | 1181 | ±24 | |
| Nuclear grade | ||||
| 1 | 66 (16) | 1210 | ±45 | 0.493 |
| 2 | 230 (55) | 1170 | ±23 | |
| 3 | 123 (29) | 1212 | ±34 | |
| Tumor size | ||||
| x<2 cm | 141 (34) | 1177 | ±30 | 0.927 |
| 2 cm≤x <5 cm | 195 (47) | 1192 | ±25 | |
| 5 cm ≤ x | 78 (19) | 1192 | ±43 |
*
P values <0.05
**
P values <0.01
***
P values <0.001